Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center. - Wikidata - wikimedia - TriplyDB

Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.

Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.

http://www.wikidata.org/entity/Q34058137

about

Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus.Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.Extended Infusion of Piperacillin/Tazobactam in Children.Hospital Length of Stay Among Patients Receiving Intermittent Versus Prolonged Piperacillin/Tazobactam Infusion in the Intensive Care Units.Evaluation of an alternative extended-infusion piperacillin-tazobactam dosing strategy for the treatment of gram-negative infections.Targeted benefits of prolonged-infusion piperacillin-tazobactam in an in vitro infection model of Pseudomonas aeruginosa.Optimal infusion rate in antimicrobial therapy explosion of evidence in the last five years

P2860

Q36089167-AF3B424B-FD75-4C79-ABC4-3319F899279F Q37250189-7F13FA00-FD82-4DE6-9042-9E908C73F2A9 Q38705266-4BD6ACA0-E3DD-4520-963D-11FC605A2DA2 Q38714853-2C62F3ED-2E4D-4BDB-B58B-33ADF0630E8F Q40219976-3BD3CDD5-A7BA-4FCD-AF08-DFD61FCD79D2 Q40687385-4D226380-DFDF-483A-BECC-CF847514E16F Q40714798-D7419187-08EE-40F4-8C26-3A1FBF14E5FE Q58795590-BB1C0EFC-2EAB-4B3B-A568-B23E14CEA1EB

P2860

Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.

http://www.wikidata.org/entity/Q34058137

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Extended-Infusion versus stand ...... at a tertiary medical center.

@ast

Extended-Infusion versus stand ...... at a tertiary medical center.

@en

Extended-Infusion versus stand ...... at a tertiary medical center.

@nl

type

label

Extended-Infusion versus stand ...... at a tertiary medical center.

@ast

Extended-Infusion versus stand ...... at a tertiary medical center.

@en

Extended-Infusion versus stand ...... at a tertiary medical center.

@nl

prefLabel

Extended-Infusion versus stand ...... at a tertiary medical center.

@ast

Extended-Infusion versus stand ...... at a tertiary medical center.

@en

Extended-Infusion versus stand ...... at a tertiary medical center.

@nl

P1433

Q34058137-1FCD2BA9-07F6-43B9-9595-62EF35D32B9C

P1476

Q34058137-19125A9F-0AC6-445F-BD74-F941AC4133EC

P2093

Q34058137-50108F13-1CB9-43D7-85F5-42BD4DCCBA4E

Q34058137-5CBC34B8-4C10-4A6D-BD3D-7B415E965933

Q34058137-5CD717FE-DA32-44C8-8724-2F05426E74EA

Q34058137-66A75FDB-F4DD-4E56-A5AD-739CFFC9C0AF

Q34058137-71D888A5-6908-4017-BD72-7EE419C3A853

Q34058137-724C5959-A7C5-4A0A-8DA8-973337FD58B3

Q34058137-9D7C4166-F9A0-4DAA-909A-42B2F36E0043

Q34058137-D9307EBB-8986-41EE-B078-6B757C085341

Q34058137-EE8029F6-30A1-4A73-86F1-ACCAF4D5B3D6

P2860

Q34058137-0250EF9A-9A9F-4A3F-B437-633666443838

Q34058137-1DDA8740-CB69-4629-B997-A13EBD47F0D8

Q34058137-1F8C566B-019E-479F-9171-A442E3E24301

Q34058137-21C623A6-9FA6-4FAE-BA65-765D8E4032B5

Q34058137-3DC97E8D-23F0-4C4B-A8CE-D26753FC5F75

Q34058137-54760595-4233-481D-B949-08E48053160C

Q34058137-5BCBB3D5-FDE1-4414-97C7-B27D43259388

Q34058137-797746D7-6714-4B1A-A2D3-65D2996FC477

Q34058137-835B9D12-0EBD-4C8E-8B2A-8DAFD516379F

Q34058137-8A342817-E747-4A0C-87E2-2356F1155E17

P304

Q34058137-DD9B6D86-312F-4EF1-B6B3-A12F370EDFA1

P31

Q34058137-E36D10CF-D110-4E8D-BD06-24CDF892F13E

P356

Q34058137-F8B1E31E-9C8A-4CAB-9016-BC3237D29872

P407

Q34058137-CA4080AD-8124-4F72-B416-6E343CCE010E

P433

Q34058137-2779AFD3-69B2-4C49-AA6B-C19A4CE4375D

P478

Q34058137-EADF26DC-CCF5-4DA1-A727-3661FD647C99

P50

Q34058137-61F74EE1-686D-4745-853C-92E6C97A36BE

P577

Q34058137-63373805-8918-4AC1-B497-E777B0B2D91E

P5875

Q34058137-5759A7A6-7373-4A6F-A3AE-1D3171D8A6B4

P698

Q34058137-FA46CB06-D37C-4FC1-92EB-07A47657AF90

P921

Q34058137-12DDCCBF-0936-4138-AD14-7AE9AC278CF0

P932

Q34058137-7645ADD5-794B-4D16-A367-E6B1061C21D4

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Extended-Infusion versus stand ...... at a tertiary medical center.

@en

P2093

Donald Chen

http://www.w3.org/2001/XMLSchema#string

John Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Marco R Scipione

http://www.w3.org/2001/XMLSchema#string

Robert Holzman

http://www.w3.org/2001/XMLSchema#string

Sapna A Mehta

http://www.w3.org/2001/XMLSchema#string

Scott R Cutro

http://www.w3.org/2001/XMLSchema#string

Tania Ahuja

http://www.w3.org/2001/XMLSchema#string

Xian Jie Cindy Chen

http://www.w3.org/2001/XMLSchema#string

Yanina Dubrovskaya

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

Influence of culture site-specific MIC distributions on the pharmacokinetic and pharmacodynamic properties of piperacillin/tazobactam and piperacillin: a data analysis.

Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings.

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.

Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.

The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.

P304

4470-4475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02759-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Michael S Phillips

P577

2014-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262681019

http://www.w3.org/2001/XMLSchema#string

P698

24867975

http://www.w3.org/2001/XMLSchema#string

P921

P932

4136013

http://www.w3.org/2001/XMLSchema#string